(Q34007177)

30 July 2017

1 reference

title

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. (English)

1 reference

30 July 2017

0 references

Hauber AB

1

1 reference

30 July 2017

Gnanasakthy A

2

1 reference

30 July 2017

Snyder EH

3

1 reference

30 July 2017

Bala MV

4

1 reference

30 July 2017

Richter A

5

1 reference

30 July 2017

Mauskopf JA

6

1 reference

30 July 2017

language of work or name

1 reference

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

351-360

1 reference

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Cognitive function and the costs of Alzheimer disease. An exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Progression of cognitive impairment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200017040-00005

Rates of change of common measures of impairment in senile dementia of the Alzheimer's type

21 January 2018

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

10.2165/00019053-200017040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1018900237

0 references

1 reference